Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2017, Article ID 2191532, 6 pages
https://doi.org/10.1155/2017/2191532
Research Article

Detection of Methicillin Resistant Staphylococcus aureus and Determination of Minimum Inhibitory Concentration of Vancomycin for Staphylococcus aureus Isolated from Pus/Wound Swab Samples of the Patients Attending a Tertiary Care Hospital in Kathmandu, Nepal

1Department of Microbiology, Goldengate International College, Battisputali, Kathmandu, Nepal
2Department of Microbiology, Grande International Hospital, Dhapasi, Kathmandu, Nepal
3Central Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal
4Department of Microbiology, Nepalese Army Institute of Health Sciences, Sanobharyang, Kathmandu, Nepal

Correspondence should be addressed to Narayan Dutt Pant; moc.liamg@7891tnapdn

Received 9 September 2016; Accepted 14 December 2016; Published 5 January 2017

Academic Editor: Jorge Garbino

Copyright © 2017 Raghabendra Adhikari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Graveland, B. Duim, E. van Duijkeren, D. Heederik, and J. A. Wagenaar, “Livestock-associated methicillin-resistant Staphylococcus aureus in animals and humans,” International Journal of Medical Microbiology, vol. 301, no. 8, pp. 630–634, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Monecke, G. Coombs, A. C. Shore et al., “A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus,” PLoS ONE, vol. 6, no. 4, Article ID e17936, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. W. J. Gould, P. Cuschieri, J. Rollason, A. C. Hilton, S. Easmon, and M. D. Fielder, “The need for continued monitoring of antibiotic resistance patterns in clinical isolates of Staphylococcus aureusfrom London and Malta,” Annals of Clinical Microbiology and Antimicrobials, vol. 9, article 20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. H. Deurenberg, C. Vink, S. Kalenic, A. W. Friedrich, C. A. Bruggeman, and E. E. Stobberingh, “The molecular evolution of methicillin-resistant Staphylococcus aureus,” Clinical Microbiology and Infection, vol. 13, no. 3, pp. 222–235, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Barber, “Methicillin-resistant staphylococci,” Journal of Clinical Pathology, vol. 14, pp. 385–393, 1961. View at Publisher · View at Google Scholar · View at Scopus
  6. H. F. Chambers and F. R. DeLeo, “Waves of resistance: Staphylococcus aureus in the antibiotic era,” Nature Reviews Microbiology, vol. 7, no. 9, pp. 629–641, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Prabhu, S. Rao, and V. Rao, “Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples,” Journal of Laboratory Physicians, vol. 3, no. 1, pp. 25–27, 2011. View at Publisher · View at Google Scholar
  8. A. O. Kshetry, N. D. Pant, R. Bhandari et al., “Minimum inhibitory concentration of vancomycin to methicillin resistant Staphylococcus aureus isolated from different clinical samples at a tertiary care hospital in Nepal,” Antimicrobial Resistance & Infection Control, vol. 5, no. 1, article 27, 2016. View at Publisher · View at Google Scholar
  9. M. M. Baddour, M. M. Abuelkheir, and A. J. Fatani, “Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia,” Annals of Clinical Microbiology and Antimicrobials, vol. 5, article 30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Koyama, J. Inokoshi, and H. Tomoda, “Anti-infectious agents against MRSA,” Molecules, vol. 18, no. 1, pp. 204–224, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. S. J. Rehm, “Staphylococcus aureus: the new adventures of a legendary pathogen,” Cleveland Clinic Journal of Medicine, vol. 75, no. 3, pp. 177–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Torimiro, “Analysis of Beta-lactamase production and antibiotics resistance in Staphylococcus aureus strains,” Journal of Infectious Diseases and Immunity, vol. 5, no. 3, pp. 24–28, 2013. View at Publisher · View at Google Scholar
  13. H. Grundmann, M. Aires-de-Sousa, J. Boyce, and E. Tiemersma, “Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public threat,” The Lancet Infectious Diseases, vol. 368, pp. 874–885, 2006. View at Google Scholar
  14. T. Ito, Y. Katayama, K. Asada et al., “Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 5, pp. 1323–1336, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. A. P. Johnson, “Methicillin-resistant Staphylococcus aureus: the European landscape,” Journal of Antimicrobial Chemotherapy, vol. 66, no. S4, Article ID dkr076, pp. iv43–iv48, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. L. K. Khanal and B. K. Jha, “Prevalence of methicillin resistant Staphylococcus aureus (MRSA) among skin infection cases at a hospital in Chitwan, Nepal,” Nepal Medical College Journal, vol. 12, no. 4, pp. 224–228, 2010. View at Google Scholar · View at Scopus
  17. B. Shrestha, “Comparative prevalence of MRSA in two Nepalese tertiary care hospitals,” Open Journal of Clinical Diagnostics, vol. 3, no. 2, pp. 67–73, 2013. View at Publisher · View at Google Scholar
  18. B. A. Forbes, D. F. Sahm, and A. S. Weissfeld, Bailey and Scott's Diagnostic Microbiology, Mosby Inc, Maryland Heights, Mo, USA, 12th edition, 2007.
  19. Clinical and Laboratory Standards Institute, “Performance standards for antimicrobial susceptibility testing: twenty third informational supplement edition,” CLSI Document M100-S23, CLSI, Wayne, Pa, USA, 2013. View at Google Scholar
  20. J. M. Andrews, “Determination of minimum inhibitory concentrations,” Journal of Antimicrobial Chemotherapy, vol. 48, no. 1, pp. 5–16, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. Clinical and Laboratory Standardrs Institute, CLSI Document M07-A9. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard-Ninth Edition, CLSI, Wayne, Pa, USA, 2012.
  22. S. A. Samant and C. G. Pai, “Comparative evaluation of β-lactamase detection methods in Staphylococci,” International Journal of Pharma and Bio Sciences, vol. 3, pp. 1580–1588, 2012. View at Google Scholar
  23. J. Sambrook, D. W. Russell, N. Irwin, and K. A. Jansen, Molecular Cloning: A Laboratory Manual, vol. 1, 2, 3, Cold Spring Harbor Laboratory Press, New York, NY, USA, 12th edition, 2001.
  24. H. M. Abu Shady, A. K. El-Essawy, M. S. Salama, and A. M. El-Ayesh, “Detection and molecular characterization of vancomycin resistant Staphylococcus aureus from clinical isolates,” African Journal of Biotechnology, vol. 11, pp. 16494–16503, 2012. View at Google Scholar
  25. R. Sanjana, R. Shah, N. Chaudhary, and Y. Singh, “Prevalence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus (MRSA) in CMS-teaching hospital: a preliminary report,” Journal of College of Medical Sciences-Nepal, vol. 6, no. 1, pp. 1–6, 2010. View at Publisher · View at Google Scholar
  26. S. Subedi and K. N. Brahmadathan, “Antimicrobial susceptibility patterns of clinical isolates of Staphylococcus aureus in Nepal,” Clinical Microbiology and Infection, vol. 11, no. 3, pp. 235–237, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Baral, B. Khanal, and A. Acharya, “Antimicrobial susceptibility patterns of clinical isolates of Staphylococcus aureus in Eastern Nepal,” Health Renaissance, vol. 9, no. 2, pp. 78–82, 2011. View at Publisher · View at Google Scholar
  28. H. K. Tiwari, A. K. Das, D. Sapkota, K. Sivarajan, and V. K. Pahwa, “Methicillin resistant Staphylococcus aureus: prevalence and antibiogram in a tertiary care hospital in western Nepal,” Journal of Infection in Developing Countries, vol. 3, no. 9, pp. 681–684, 2009. View at Google Scholar · View at Scopus
  29. B. A. Mir and Srikanth, “Prevalence and antimicrobial susceptibility of methicillin resistant Staphylococcus aureus and coagulase-negative Staphylococci in a tertiary care hospital,” Asian Journal of Pharmaceutical and Clinical Research, vol. 6, no. 3, pp. 231–234, 2013. View at Google Scholar
  30. A. R. Kumar, “Antimicrobial sensitivity pattern of Staphylococcus aureus isolated from pus from tertiary care hospital, Surendranagar, Gujarat and issues related to the rational selection of antimicrobials,” Scholars Journal of Applied Medical Sciences, vol. 1, pp. 600–605, 2013. View at Google Scholar
  31. S. Dibah, M. Arzanlou, E. Jannati, and R. Shapouri, “Prevalence and antimicrobial resistance pattern of methicillin resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens in Ardabil, Iran,” Iranian Journal of Microbiology, vol. 6, no. 3, pp. 163–168, 2014. View at Google Scholar · View at Scopus
  32. S. Ansari, H. P. Nepal, R. Gautam et al., “Threat of drug resistant Staphylococcus aureus to health in Nepal,” BMC Infectious Diseases, vol. 14, article no. 157, 2014. View at Publisher · View at Google Scholar
  33. K. R. Fiebelkorn, S. A. Crawford, M. L. McElmeel, and J. H. Jorgensen, “Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative Staphylococci,” Journal of Clinical Microbiology, vol. 41, no. 10, pp. 4740–4744, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Shrestha and S. Rana, “Comparative study of three β lactamase test methods in Staphylococcus aureus isolated from two Nepalese hospitals,” Open Journal of Clinical Diagnostics, vol. 4, no. 1, pp. 47–52, 2014. View at Google Scholar
  35. M. Kaase, S. Lenga, S. Friedrich et al., “Comparison of phenotypic methods for penicillinase detection in Staphylococcus aureus,” Clinical Microbiology and Infection, vol. 14, no. 6, pp. 614–616, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. L. K. McDougal and C. Thornsberry, “The role of β-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins,” Journal of Clinical Microbiology, vol. 23, no. 5, pp. 832–839, 1986. View at Google Scholar · View at Scopus
  37. A. Farahani, P. Mohajeri, B. Gholamine, M. Rezaei, and H. Abbasi, “Comparison of different phenotypic and genotypic methods for the detection of methicillin-resistant Staphylococcus aureus,” North American Journal of Medical Sciences, vol. 5, no. 11, pp. 637–640, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J. M. Boyce and A. A. Medeiros, “Role of β-lactamase in expression of resistance by methicillin-resistant Staphylococcus aureus,” Antimicrobial Agents and Chemotherapy, vol. 31, no. 9, pp. 1426–1428, 1987. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Barber and M. Rozwadowska-Dowzenko, “Infection by penicillin-resistant staphylococci,” The Lancet, vol. 252, no. 6530, pp. 641–644, 1948. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Ballhausen, A. Kriegeskorte, N. Schleimer, G. Peters, and K. Becker, “The mecA homolog mecC confers resistance against β-lactams in Staphylococcus aureus irrespective of the genetic strain background,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 7, pp. 3791–3798, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. V. D. Bennimath, C. C. Gavimath, P. B. Kalburgi, and C. Kelmani, “Amplification and Sequencing of mecA gene from methicillin resistant Staphylococcus aureus,” International Journal of Advanced Biotechnology and Research, vol. 2, pp. 310–314, 2011. View at Google Scholar
  42. F.-J. Chen, I.-W. Huang, C.-H. Wang et al., “mecA-positive Staphylococcus aureus with low-level oxacillin MIC in Taiwan,” Journal of Clinical Microbiology, vol. 50, no. 5, pp. 1679–1683, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Gardete and A. Tomasz, “Mechanisms of vancomycin resistance in Staphylococcus aureus,” Journal of Clinical Investigation, vol. 124, no. 7, pp. 2836–2840, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Rossi, L. Diaz, A. Wollam et al., “Transferable vancomycin resistance in a community-associated MRSA lineage,” The New England Journal of Medicine, vol. 370, no. 16, pp. 1524–1531, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Amatya, P. Devkota, and A. Gautam, “Reduced susceptibility to vancomycin in methicillin resistant Staphylococcus aureus: a time for action,” Nepal Medical College Journal, vol. 16, no. 1, pp. 42–44, 2014. View at Google Scholar · View at Scopus
  46. P. C. Pahadi, U. T. Shrestha, N. Adhikari, P. K. Shah, and R. Amatya, “Growing resistance to vancomycin among methicillin resistant Staphylococcus aureus isolates from different clinical samples,” Journal of Nepal Medical Association, vol. 52, no. 196, pp. 977–981, 2014. View at Google Scholar